SPONSOR
Centre Hospitalier Universitaire de Besancon
Total Trials
12
Recruiting
12
Phases
Phase 2, Phase 3, Phase 1, Phase 2, Phase 2
Conditions studied: Antibody-mediated Rejection in Kidney TransplantBreast CancerMetastatic Colorectal CancerOesophagus CancerElderly PatientsAtrial FibrillationCritical IllnessHealthy VolunteersBehavior and Behavior MechanismsCutaneous T-Cell Lymphoma
Centre Hospitalier Universitaire de Besancon is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Antibody-mediated Rejection in Kidney Transplant, Breast Cancer, Metastatic Colorectal Cancer, Oesophagus Cancer.
The trial portfolio spans Phase 2, Phase 3, Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Centre Hospitalier Universitaire de Besancon
How many clinical trials has Centre Hospitalier Universitaire de Besancon sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by Centre Hospitalier Universitaire de Besancon, of which 12 are actively recruiting participants. These trials cover conditions including Antibody-mediated Rejection in Kidney Transplant, Breast Cancer, Metastatic Colorectal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Centre Hospitalier Universitaire de Besancon research focus on?
Centre Hospitalier Universitaire de Besancon clinical trials span Antibody-mediated Rejection in Kidney Transplant, Breast Cancer, Metastatic Colorectal Cancer, Oesophagus Cancer, Elderly Patients, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Centre Hospitalier Universitaire de Besancon clinical trial?
To participate in a Centre Hospitalier Universitaire de Besancon trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Centre Hospitalier Universitaire de Besancon trials with current recruitment status updated daily.
Clinical Trials by Centre Hospitalier Universitaire de Besancon
NCT07663669
Recruiting
Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection
Antibody-mediated Rejection in Kidney Transplant
NCT06185569
Recruiting
FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy
Breast Cancer
NCT05462613 Phase 2, Phase 3
Recruiting
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
NCT02735057 Phase 1, Phase 2
Recruiting
Chemoradiotherapy in Elderly Patients With Oesophagus Cancer
Oesophagus Cancer
NCT05860894
Recruiting
Post Intensive Care Unit Atrial Fibrillation
Atrial Fibrillation
NCT06337500
Recruiting
Validation of a Making Decision Hybrid (Ecologic and Virtual) Task
Healthy Volunteers
NCT05333367
Recruiting
MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy
Cutaneous T-Cell Lymphoma
NCT04853173
Recruiting
Modality of Pain Management in Ambulatory Tonsillectomy Surgery in Adults
Tonsillar Disorder
NCT07036380 Phase 2
Recruiting
MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma
Advanced Biliary Tract Carcinoma
NCT06425133 Phase 2
Recruiting
Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
Metastatic Colorectal Cancer
NCT06112509
Recruiting
Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery
Vestibular Schwannoma
NCT05824442
Recruiting
Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of Echinococcosis
Echinococcosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology